Transcription of Heart Failure Medication Titration Plan
{{id}} {{{paragraph}}}
Heart F AILURE (HF) Medication OPTIMISATION - 08/2022DO NOT WRITE IN THIS BINDING MARGINPage 1 of 2 URN:Family name:Given name(s):Address:Date of birth: Sex: M F IHeart Failure (HF) MedicationOptimisation Plan State of Queensland (Queensland Health) 2022 Licensed under: : .. Dear ..Pl ea se op timise this patie nt s he art fai lure med ic ationsandcall the n umber below if there are an y sultsEF %:Date Wei ght (kg)eGFR mL/minK+ mmol /LBP mmHgHR bpmMonit oring recommendations(see overl eaffor guid ance) Checkbl ood pr essure(BP) inc lu dingposturaldrop andhe art rate (HR)eachvisit ACEI/ARB/ARNI/ MRA*: check serum potassiu m (K+), renal function 1-2 week/s after commenci ng or titrating(if K+ is high recheck in 48 hou rs).
channel blockers (verapamil, diltiazem) in patients with heart failure with reduced ejection fraction (HFrEF). •Asymptomatic hypotension does not usually require any change in therapy (systolic BP 90–100 mmHg) Symptomatic hypotension (dizziness, light-headedness and/or confusion): I. Stop or reduce calcium - channel blockers
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}